Profile image
Story Views

Last Hour:
Last 24 Hours:

Global Ischemic Heart Disease (IHD) Drugs Market : applications & Industry chain overview

Wednesday, November 9, 2016 1:47
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Bigmarketresearch added Most up-to-date research on “Global Ischemic Heart Disease (IHD) Drugs Market 2015-2019″ to its huge collection of research reports.

About IHD

IHD is an abnormal condition of the human body marked by narrowing or blocking of the arteries that supply blood to the heart. It results from the buildup of plaque in the arteries. The condition often arises during excitement and exertion when heart requires more blood supply. This leads to recurrent chest pain and discomfort due to lack of sufficient blood supply, a condition known as angina pectoris.

Prolonged blockage of the arteries due to lack of blood supply may result in death of tissues in the heart, leading to myocardial infarction. The symptoms develop slowly, and in most cases the condition is asymptomatic until it reaches the last stages. The common indications include chest pain and shortness of breath. Treatment options are available depending on the condition of the patient. A range of medications of different classes, such as statins, antiplatelet drugs, nitrates, beta-blockers, etc. can be chosen from. Surgical procedures, such as angioplasty and coronary artery bypass graft, are also opted in serious scenarios. Analysts forecast the global IHD drugs market to grow at a CAGR of 3.61% during 2014-2019.

Download sample copy of report here @

Covered in this Report

The report covers the present scenario and the growth prospects of the global IHD drugs market for the period 2015-2019. To calculate the market size, we consider the revenue generated from the sales of various branded therapies and generics, along with the drugs used as off-label for the treatment of IHD. IHD includes:

• Angina pectoris

• Myocardial infarction.

Global IHD Drugs Market 2015-2019, is based on an in-depth market analysis, with inputs from industry experts. We covers the Americas, APAC and EMEA markets. We also discuss the key vendors operating in this market.

Key Regions

• Americas

• EMEA       


Ask for discount here @

Key Vendors

• AstraZeneca

• Bayer

• Eli Lilly

• Novartis

• Pfizer

• Sanofi

Other Prominent Vendors

• Actelion

• Amgen

• Baxter

• Boehringer Ingelheim

• Bristol-Myers Squibb

• Daiichi-Sankyo

• Eisai

• F.Hoffmann-La Roche

Market Driver

• Rise in Number of Patients

• For a full and detailed list, view our report

Market Challenge

• Delayed Diagnosis

• For a full and detailed list, view our report

Market Trend

• Increase in Health Awareness

• For a full and detailed list, view our report

Read complete report here @

Contact Us :

Dhananjay Potle

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Direct :+ 1-503-894-6022

Toll Free :  + 1-800-910-6452





Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.